Jorge Moll: Studying Altruism and its Positive Effects

Altruism is a human characteristic that is described as the strong urge to help someone who needs assistance. Two neuroscientists from Brazil decided to study the altruistic behavior of humans, and they wanted to find out the origin of this human characteristic. The first study about the correlation of altruism and the human mind was conducted in 2006, and the neuroscientists, led by Jorge Moll and Jordan Grafman, had to invite several volunteers who would be going under several tests and examinations. The volunteers were collected inside an empty room, and inside, Jorge Moll and Jordan Grafman explained to them what they are going to do. The two neuroscientists explained the objective of the study, and they gave instructions to the volunteers on what they are going to do while the experiment is going on. Follow Jorge Moll on Linkedin.

When the experiment began, the volunteers had to close their eyes and think about two different scenarios – one is about generosity, and the other is about selfishness. Jorge Moll and Jordan Grafman then check the brain scanner to see any activities that are happening inside the brain. After the experiment, they reviewed the scanner, and they were surprised to see that the brain is active when an individual thinks about generosity. The opposite is true when one thinks about selfishness, and the brain does not react at all. Watch this video on

Jorge Moll and Jordan Grafman also found out about a small portion of the brain which releases hormones and chemicals that are responsible for the pleasure that an individual feels when he or she gives to charities or any person who is in need. The study that they conducted proves that the altruistic behavior in humans is innate in everyone and the urge to help someone is a natural reaction to the environment.

Jorge Moll and Jordan Grafman shared the research that they made to the scientific community, and a lot of the scientists have congratulated them for a well-researched study which tackles about the human brain. The study conducted by Jorge Moll and Jordan Grafman managed to answer some questions, but it also opened a lot of doors that have to be answered later on.


Oncotarget targets holistic approaches to cancer

Those who suffer from papillary thyroid carcinoma already know going into it that they will likely get to the point where there is no hope to defeat their cancer. This is because papillary thyroid carcinoma so often develops a bodily resistance to vemurafenib. The reason this bodily resistance occurs to the medicine is that vemurafenib specifically target a mutated BRAF gene. The body sees vemurafenib as a foreign agent in the same category as a virus. It then responds to vemurafenib by sending white blood cells to defeat it. This drug-resistant cancer so often gets to the point that it becomes incurable and those with papillary thyroid carcinoma must accept their fate that they will die from this cancer. Follow Oncotarget on Linkedin.

The nationally peer-reviewed Oncotarget Journal recently sat down with Dr. Carmelo Nucero to discuss his latest research that suggests there is a way to stop papillary thyroid carcinoma from becoming drug-resistant. Oncotarget is a holistic peer-reviewed journal that focuses on the pathological consequences that occur to a patient who is diagnosed with cancer and undergoes cancer treatment.

Dr. Carmelo Nucero is reporting that he has discovered a way to decrease the likelihood that papillary thyroid carcinoma will become resistant to vemurafenib. For those who may not know, vemurafenib is the most common drug used to treat this most common kind of thyroid cancer. If Dr. Carmelo Nucero can get papillary thyroid carcinoma to stop resisting vemurafenib, then he will be able to keep papillary thyroid carcinoma curable for the majority of patients.

Dr. Carmelo Nucero discovered that if the drug palbociclib, which is used to treat women with stage IV breast cancer, is mixed with vemurafenib the nearly miraculous results happen. Learn more at

He found that the combination of these drugs, when used in a therapeutic way, can induce stronger cancer cell death while also promoting healthier cell regeneration. He is hopeful that since both vemurafenib and palbociclib have already been approved by the FDA as solitary drugs that after a few months of trials they can be approved together. Stay tuned on Oncotarget’s podcast for more information which is coming soon.

Learn more:

The Leadership of Highland Capital Management Committed to Excellence

As the savvy veteran leadership of Highland Capital Management strives to produce continuing above-average returns, one question recurs more frequently than most: What broad range of products do its SEC-registered investment advisers offer institutional and retail investors?

In 1993, James Dondero and Mark Okada had a revolutionary vision based on a unique investing concept which later evolved into an independently-owned investment firm. Headquartered in Dallas, Highland Capital Management has became one of the world’s largest and trusted global managers of alternative credit. The Texas-based firm has an industrious team of 180-plus employees working around the world: Buenos Aires, New York City, São Paulo, Seoul, and Singapore. Read more at Biz Journals about Highland Capital.

The firm’s diversified client base is comprised of affluent individuals, corporations, endowments, financial institutions, foundations, governments, and public pension plans.

What does Highland Capital Investment know?

The decades-old investment firm, with 20-plus years of experience, knows alternative investment. As the leader of multibillion-dollar global alternative investment, the firm has…

  • 1. Pioneered the market based on a form of securitization called collateralized loan obligation (CLO).
  • 2. Created one of the first non-bank CLO’s ever in 1996.
  • 3. Structured and monitored over $30 billion of collateralized loan obligations and collateralized debt obligations (CDO).
  • 4. Remained one of the world’s largest CLO managers.

Today, many of Highland Capital clients understand how profitable alternative investment can be. Its employees, each of whom specializes in credit strategies, meet with valued clients at each of the firm’s location around the world. The employees specialize in credit hedge funds, distressed and special situations private equity, long-only funds and separate accounts, and collateralized loan obligations. Read this article at PR Newswire.

Since its inception, the firm has also offer alternative investment opportunities: natural resources, emerging markets, and long/short equities. With decades of experience and a wealth of investment knowledge, the firm is the authoritative source of alternative investment. If you need sound advice with which to make a well-informed investing decision, do not hesitate to contact the firm founded by Dondero and Okada. Get the facts and decide what action you ought to take next. You will be glad you made the decision.


End Citizens United to Focus on 2018 Congressional Seats in California.

There is a changing of the guard in Washington D.C. as Donald Trump continues his reign as one of the most destructive forces in the history of the Presidency. The Trump administration has leaned into and profited directly from the 2010 Supreme Court ruling on Citizens United, a conservative group that argued for loosened restrictions surrounding campaign financial contributions. In the intervening years since that monumental decision, you can draw a direct line between the influx of dark money into politics and the rise of dangerous candidates like Trump. There is a political action committee that was created in 2015 that has been doing their best to fight this rise of dangerous money in politics and their name is also their mission statement: End Citizens United. End Citizens United is making it their mission to fight back against the rising tide of dark money by supporting legislators during the important 2018 midterm congressional elections.

End Citizens United is being led by Tiffany Muller, the president at the PAC. Muller has made major headway over her two years of leadership by spreading the word and organizing grassroots support for the mission of ending the dangerous Citizens United decision. Now, with the 2018 congressional elections looming, End Citizens United is mobilizing for an important year. In order to amend the Citizens United decision, there needs to be brave legislators in the House that are willing to introduce legislation to bring about change. That is why End Citizens United will be targeting four important California House seats belong to: Dana Rohrabacher (Costa Mesa), Darrell Issa (Vista), Duncan Hunter (Alpine), and Mimi Walters (Irvine).

Last year during the 2016 Presidential Election, End Citizens United was active in their support for progressive legislators that were willing to champion campaign finance reform. The PAC put nearly $25 million into their support for a variety of different legislators and that will probably be the goal once again in 2018. End Citizens United has already raised close to $12 million as of October 30th, according to reports released by the Federal Exchange Commissions. While End Citizens United has not committed that money to congressional support, it shows that End Citizens United is already raising serious cash and that people are responding to their message.

The rise of Donald Trump and the corresponding chaos that has ensued in Washington D.C. cannot be understated, particularly when it comes to the future of the United States as a nation. When companies can pour money into the government in order to purchase their own legislators, it creates the fundamental problem that American voters are being completely ignored. If American voters want to find power at the ballot box once again, they’ll show up in droves in support of candidates willing to champion campaign finance reform such as End Citizens United.

Read More:

Jason Hope’s Recent Release: “Understanding the Internet-Of-Things Revolution: A Quick Guide for Thriving in the IoT Era”

Jason Hope’s new e-book, “Understanding the Internet of Things Revolution: A Quick Guide for Thriving in the IoT Era,” has recently been released on Amazon.

The Internet of Things

The “internet of things” refers to the large network of different devices that can connect either to each other or to the internet. The internet of things includes things we use in our everyday lives like smartphones and medical devices.

The internet of things, however, doesn’t just affect consumers. It also has a significant impact on many different industries, and it is changing the way that businesses operate. By the year 2020, the Gartner analyst firm believes that the internet of things will contain over 26 million devices, including things as important as jet engines and oil drills.

About the Book

This e-book provides an accurate, concise explanation of what the “internet of things” is and how it works. Near the beginning of the book, Jason Hope points out the fact that technology is involved in nearly every aspect of our daily lives in  modern world. He even refers to it as a “disruptive source of innovation,” but Hope also acknowledges that many different industries has been able to use the internet to solve problems and do thins more efficiently.

Later, he goes on to explain how we can correctly use the modern technology network in our homes to improves our safety. Hope places a lot of emphasis on using the internet of things in the most responsible way possible.

About the Author

Jason is based in Scottsdale, Arizona, and he is an entrepreneur, philanthropist and futurist. He holds an MBA from Arizona State University’s W.P. Carey School of Business. Hope recently gave the SENS Foundation, a nonprofit that researches bio-technologies and age-related diseases, a $500,000 donation.

For someone who is new to the “internet of things” concept, his e-book will be a great and informative introduction.

Jason Hope’s Social Media:

How Organo Gold Coffee Can Help You Live Longer and Stay Healthy

Organo Gold values itself as a lifestyle brand. Since 2008, the company has offered a variety of premium coffees infused with exotic ingredients that boost the health benefits of their consumers and contribute to the company’s ideologies of balance, freedom, well-being, and maximum happiness. Now, according to two new studies in the Annals of Internal Medicine, coffees like those sold by Organo Gold could also help you live longer. Organo Gold is available on eBay.

These studies found that drinking multiple cups of coffee each day decreases the chances of succumbing to ailments like cancer, diabetes, heart disease, or kidney disease by 18 percent. One study was conducted in America over a 16-year period with participants of various racial and ethnic backgrounds, and the other was conducted in Europe across 10 different countries. These studies observed a combined total of approximately 750,000 participants. Visit to know more about Organo Gold.

Prolonging life and decreasing the chances of disease are just the newest health benefits being discovered in coffee. Coffee also contains multiple antioxidants, such as quinic acid, which is also found in fruits and plants, and chlorogenic acid. Some brands of coffee even feature added ingredients to boost health benefits.

Organo Gold beverages also contain Ganoderma lucidum, a type of red Reishi mushroom used in Chinese herbal medicine and widely known throughout Asia as “King of the Herbs.” Ganoderma lucidum provides a mild nutty flavor to the coffee while infusing it with amino acids. It also provides triterpenoids, like those found in honey and fruits, and adds fiber.

Ganoderma lucidum can be found in all five Organo Gold coffees: Gourmet Black Coffee, King of Coffee, Cafe Latte, Cafe Mocha, and Cafe Supreme. Organo Gold’s Cafe Supreme contains additional herbs also used in Chinese medicine. This includes Ginseng, traditionally used for its rejuvenation properties, and Eurycoma longifolia, also known as Malaysian Ginseng.